Salicyl Alcohol

Salicyl Alcohol

SCHEMBL8589411

OCc1ccccc1O.c1cc2ccc1CO2

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSPA5 P11021 1/20 0.41
▸ MPO P05164 2/20 0.38
▸ TSHR P16473 2/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.36
▸ AKR1B1 P15121 1/20 0.36
▸ CA12 O43570 4/20 0.35
▸ CA2 P00918 4/20 0.35
▸ IDO1 P14902 2/20 0.35
▸ CA9 Q16790 3/20 0.34
▸ KEAP1 Q14145 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Salicyl Alcohol SCHEMBL15639 0.77 — —
Salicyl Alcohol SCHEMBL17028795 0.77 HSPA5 (0.65) HSPA5MPOTSHRCYP2D6HIF1A
Salicyl Alcohol SCHEMBL29453973 0.77 — —
Salicyl Alcohol SCHEMBL31186654 0.74 HSPA5 (0.62) HSPA5MPOTSHRCYP2D6HIF1A
Salicyl Alcohol SCHEMBL886904 0.74 HSPA5 (0.62) HSPA5MPOTSHRCYP2D6HIF1A
Salicyl Alcohol SCHEMBL10793667 0.74 HSPA5 (0.62) HSPA5MPOTSHRCYP2D6HIF1A
Salicyl Alcohol SCHEMBL11408121 0.74 HSPA5 (0.62) HSPA5MPOTSHRCYP2D6HIF1A
Salicyl Alcohol SCHEMBL28958249 0.74 HSPA5 (0.62) HSPA5MPOTSHRCYP2D6HIF1A
Salicyl Alcohol SCHEMBL20659833 0.74 HSPA5 (0.62) HSPA5MPOTSHRCYP2D6HIF1A
Salicyl Alcohol SCHEMBL29682418 0.74 HSPA5 (0.62) HSPA5MPOTSHRCYP2D6HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998037056-A1 PHENOXYPROPANOLAMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITHKLINE BEECHAM PLC (GB) 1998-08-27 — — WO disclosed
US-5726165-A HYPOGLYCEMIC AGENTS; DIETETICS; GASTROINTESTINAL DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 1998-03-10 — — US disclosed
EP-0772585-A1 ARYLOXY AND ARYLTHIOPROPANOLAMINE DERIVATIVES USEFUL AS BETA 3-ADRENORECEPTOR AGONISTS AND ANTAGONISTS OF THE BETA 1 AND BETA 2-ADRENORECEPTORS AND PHARMACEUTICAL COMPOSITION THEREOF SMITHKLINE BEECHAM PLC (GB) 1997-05-14 — — EP disclosed
WO-1996004234-A1 ARYLOXY ANDARYCTHIO PROPANOLAMINE DERIVATIVES USEFUL AS B3-ADRENORECEPTOR AGONISTS AND ANTAGONS OF THE B1 AND B2 ADRENORECEPTORS AND PHARMACEUTICAL COMPOSITION THEREOF SMITHKLINE BEECHAM PLC (GB) 1996-02-15 — — WO disclosed
WO-1996004233-A1 ARYLOXY AND ARYLTHIOPROPANOLAMINE DERIVATIVES USEFUL AS BETA 3-ADRENORECEPTOR AGONISTS AND ANTAGONISTS OF THE BETA 1 AND BETA 2-ADRENORECEPTORS AND PHARMACEUTICAL COMPOSITION THEREOF SMITHKLINE BEECHAM PLC (GB) 1996-02-15 — — WO disclosed
Send feedback